Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a value-based oncology care provider that became a public company in 2021 through a merger with DFB Healthcare Acquisitions Corp., a blank-check vehicle sponsored by DFB Capital LLC that completed its initial public offering in 2020. Operating in the healthcare sector with a focus on community-based outpatient cancer care across multiple U.S. markets, TOI filed an 8-K current report with the Securities and Exchange Commission on May 7, 2026, bearing accession number 0001079973-26-000611. For full filing history, deal analytics, and real-time SPAC data on TOI and the broader market, sign up for SpacDesk at spacdesk.com.